Eli Lilly says weight-loss pill a candidate for speedy approval under new US program

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U. Food and Drug Administration's new ...
Investor's Business Daily on MSN

Insmed Screams To A 25-Year High, While IBD 50's Argenx Slides

Insmed stock surged Thursday as Argenx stock slipped. The top-notch biotech companies beat third-quarter calls.